Innovation Pharmaceuticals Inc (IPIX)

[PlentyParanoid]

I used this study of clinical trial costs as a basis for my estimate:

https://www.centerpointclinicalservices.com/blog-posts/driving-drive-drug-innovation-and-market-access-part-1-clinical-trial-cost-breakdown/

I took average oncology phase 3 trial cost from there: $22M around 2012.

Considering the fact that Brilacidin OM trial needs to cover overall costs for radiation treatment, cisplatin treatment, Brilacidin treatment and palliative care I rounded the cost to $30M. Palliative care cost alone may hit millions if more than 40 % of total subjects develop SOM.

I did not consider this:
The probable size of Brilacidin trial - probably 200 subjects (as in Soligenix p3 trial) is about 40 to 50 % of the size for a typical P3 cancer trial (my guess). That gives about 12 to 15 M$ per trial.

The above in other way:
IPIX anticipated clinical trial costs:
12 to 15 M$ per trial. If 2 trials are required total would be 24 to 30 M$.

A factor that might make OM trials costlier: There is a good change that some OM/HNC trials are recruiting at the same time (Soligenix, Galera and IPIX).